Abstract
CABG is known to improve patient’s survival and alleviate symptoms of angina. Early saphenous vein graft failure (ESVGF), from acute thrombosis, is seen in 15-45 % of implanted grafts within the first year, a major cause of morbidity and mortality. Current guidelines recommend the sole use of
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have